Back to search

Article

Andexanet alfa-associated heparin resistance in cardiac surgery: mechanism and <i>in vitro</i> perspectives

2024-09-10

Abstract excerpt

<h4>Background</h4> Andexanet alfa (andexanet) is the only FDA-approved antidote for direct factor Xa (FXa) inhibitors but has been reported to cause resistance to unfractionated heparin (UFH). This has delayed anticoagulation for procedures requiring cardiopulmonary bypass (CPB). The mechanism, andexanet and UFH dose dependence, and thrombotic risk of andexanet-associated heparin resistance are unknown. <h4>Meth...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
403adbc6-9c26-5bae-97e1-725a5a90e3d5
DOI
10.1101/2024.09.09.612152
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Andexanet alfa-associated heparin resistance in cardiac surgery: mechanism and <i>in vitro</i> perspectivesDOI 10.1101/2024.09.09.612152
Select a neighboring publication to make it the new centre.